Skip to content
Research Article Open access CC BY 4.0

Influence of Psychotropic Drugs upon Neuropsychological Test Performance

Edward Helmes

International Neuropsychiatric Disease Journal · pp. 1–10 · Published 28 Sep 2015

10.9734/INDJ/2016/20422

Abstract

Commonly used psychotropic medications are widely presumed to have deleterious effects on neuropsychological test performance. However, given the special difficulties of neuropsychological assessment with psychiatric populations, these effects have rarely been directly examined for differential, quantitative effects on test scores. A comprehensive neuropsychological test battery is described that assesses executive functions, memory, language comprehension, motor and sensory functions, and manual praxis.  Data are presented on 233 psychiatric patients (70 females, 163 males) referred for neuropsychological assessment.  All people with known or suspected brain damage were excluded, with 100 not taking any type of psychoactive medication. Comparisons between an unmedicated group and those taking the most common medications showed differences on tests of perseverative responses and praxis. No effects for nonverbal memory, simple motor functions, basic intellectual processes or visuomotor functions were noted.  Implications for the assessment of people taking psychotropic medications are discussed.  

Psychotropic drugs neuropsychological tests psychiatric patients executive functions praxis

References (37)

  1. 1 A Modified Card Sorting Test Sensitive to Frontal Lobe Defects [DOI]
  2. 2 Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. [DOI]
  3. 3 Fundamentals of Human Neuropsychology
  4. 4 Normative Data and Screening Power of a Shortened Version of the Token Test [DOI]
  5. 5 MOTOR FUNCTIONS OF THE LEFT HEMISPHERE [DOI]
  6. 6 Searching for justice: The discovery of IQ gains over time. [DOI]
  7. 7 The Primacy of Cognition in Schizophrenia. [DOI]
  8. 8 Structural brain abnormalities in the major psychoses: A quantitative review of the evidence from computerized imaging. [DOI]
  9. 9 Frequency and bases of abnormal performance by healthy adults on neuropsychological testing [DOI]
  10. 10 Neuropsychological Performance in Older Patients With Schizophrenia: A Meta-Analysis of Cross-sectional and Longitudinal Studies [DOI]
  11. 11 Right Temporal-Lobe Damage [DOI]
  12. 12 Brain and Intelligence; A Quantitative Study of the Frontal Lobes [DOI]
  13. 13 ACQUISITION OF A MOTOR SKILL AFTER LEFT-HEMISPHERE DAMAGE [DOI]
  14. 14 Impairments on Neuropsychologic Tests of Temporohippocampal and Frontohippocampal Functions and Word Fluency in Remitting Schizophrenia and Affective Disorders [DOI]
  15. 15 Somatosensory Thresholds [DOI]
  16. 16 Change in Cognitive Functioning Following Acute Antidepressant Treatment in Late-Life Depression [DOI]
  17. 17 Use of medications with anticholinergic properties and cognitive function in a young‐old community sample [DOI]
  18. 18 Performance of Schizophrenic Patients on Tests Sensitive To Left or Right Frontal, Temporal, or Parietal Function in Neurological Patients [DOI]
  19. 19 Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients [DOI]
  20. 20 Effect of antipsychotic medication on speed of information processing in schizophrenic patients [DOI]
  21. 21 The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates [DOI]
  22. 22 Memory deficits and anticholinergic levels in chronic schizophrenia [DOI]
  23. 23 Neuropsychological Functioning in Schizophrenia Patients with First-Rank (Passivity) Symptoms [DOI]
  24. 24 Motor laterality as an indicator of speech laterality. [DOI]
  25. 25 The effect of chlorpromazine upon psychophysiological, endocrine and information processing measures in schizophrenia [DOI]
  26. 26 NEUROPSYCHOLOGICAL ASSESSMENT OF SCHIZOPHRENIA VERSUS BRAIN DAMAGE [DOI]
  27. 27 The hand dynamometer as a neuropsychological measure. [DOI]
  28. 28 Medication status of participants in psychopathology research: Selective review of current reporting practices. [DOI]
  29. 29 Phenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics [DOI]
  30. 30 Neuropsychological Measurement of Drug Effects: Polydrug Research [DOI]
  31. 31 The psychological test pattern in progressive supranuclear palsy [DOI]
  32. 32 Psychopharmacologic and clinical correlates of attention in chronic schizophrenia [DOI]
  33. 33 Parietal lobe syndrome and schizophrenia: Comparison of neuropsychological deficits. [DOI]
  34. 34 THE EFFECTS OF DRUGS ON PSYCHIATRIC PATIENTS' PERFORMANCE ON THE HALSTEAD-REITAN NEUROPSYCHOLOGICAL TEST BATTERY [DOI]
  35. 35 Effects of psychotropic drugs and psychiatric illness on vocational aptitude and interest assessment [DOI]
  36. 36 Handbook of Normative Data for Neuropsychological Assessment
  37. 37 Longitudinal course of cognitive deficits in schizophrenia.

Cited by 2

The association between symptoms of autism and neuropsychological performance in females with Anorexia Nervosa

Heather Westwood, William Mandy, Kate Tchanturia · Psychiatry Research · 2017

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

26

Page views

0

PDF downloads

2

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.